These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2722686)

  • 21. Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A.
    Morimoto S; Misawa Y; Adachi T; Nagate T; Watanabe Y; Omura S
    J Antibiot (Tokyo); 1990 Mar; 43(3):286-94. PubMed ID: 2324013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4''-carbamate, 11,12-cyclic carbonate-4''-carbamate and 11,4''-di-O-arylcarbamoyl analogs of azithromycin.
    Ma S; Ma R; Liu Z; Ma C; Shen X
    Eur J Med Chem; 2009 Oct; 44(10):4010-20. PubMed ID: 19464769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on a new antitumor antibiotic, largomycin. 3. Biological properties and antitumor activity of largomycin F-II.
    Yamaguchi T; Seto M; Oura Y; Arai Y; Enomoto K
    J Antibiot (Tokyo); 1970 Aug; 23(8):382-7. PubMed ID: 5453314
    [No Abstract]   [Full Text] [Related]  

  • 24. Naphthazarin derivatives (VII): antitumor action against ICR mice bearing ascitic S-180 cells.
    Song GY; Kim Y; You YJ; Cho H; Ahn BZ
    Arch Pharm Res; 2001 Feb; 24(1):35-8. PubMed ID: 11235809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of a new antibiotic, kazusamycin.
    Komiyama K; Okada K; Hirokawa Y; Masuda K; Tomisaka S; Umezawa I
    J Antibiot (Tokyo); 1985 Feb; 38(2):224-9. PubMed ID: 3922935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of quinocarcin derivatives: thioalkyl-substituted quinones and hydroquinones.
    Saito H; Hirata T; Kasai M; Fujimoto K; Ashizawa T; Morimoto M; Sato A
    J Med Chem; 1991 Jul; 34(7):1959-66. PubMed ID: 2066968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
    Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
    Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on antitumor agents. VII. Antitumor activities of O-alkoxyalkyl derivatives of 2'-deoxy-5-trifluoromethyluridine.
    Yamashita J; Takeda S; Matsumoto H; Unemi N; Yasumoto M
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2373-81. PubMed ID: 3664834
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
    Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship of a novel antitumor ansamycin antibiotic trienomycin A and related compounds.
    Funayama S; Anraku Y; Mita A; Yang ZB; Shibata K; Komiyama K; Umezawa I; Omura S
    J Antibiot (Tokyo); 1988 Sep; 41(9):1223-30. PubMed ID: 3182402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics.
    Gomi K; Kobayashi E; Miyoshi K; Ashizawa T; Okamoto A; Ogawa T; Katsumata S; Mihara A; Okabe M; Hirata T
    Jpn J Cancer Res; 1992 Jan; 83(1):113-20. PubMed ID: 1544867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitomycin derivatives having unique condensed-ring structures. Their synthesis and antitumor activity.
    Arai H; Kanda Y; Ashizawa T; Morimoto M; Gomi K; Kono M; Kasai M
    J Antibiot (Tokyo); 1994 Nov; 47(11):1312-21. PubMed ID: 8002396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new antitumor antibiotic, sporamycin.
    Komiyama K; Sugimoto K; Takeshima H; Umezawa I
    J Antibiot (Tokyo); 1977 Mar; 30(3):202-8. PubMed ID: 863782
    [No Abstract]   [Full Text] [Related]  

  • 34. Pre-neocarzinostatin, a specific antagonist of neocarzinostatin.
    Kikuchi M; Shoji M; Ishida N
    J Antibiot (Tokyo); 1974 Oct; 27(10):766-74. PubMed ID: 4281770
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides.
    Liang JH; An K; Lv W; Cushman M; Wang H; Xu YC
    Eur J Med Chem; 2013 Jan; 59():54-63. PubMed ID: 23202851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrronamycin A and B, novel antitumor antibiotics containing pyrrole-amide repeating unit, produced by Streptomyces sp.
    Asai A; Sakai Y; Ogawa H; Yamashita Y; Kakita S; Ochiai K; Ashizawa T; Mihara A; Mizukami T; Nakano H
    J Antibiot (Tokyo); 2000 Jan; 53(1):66-9. PubMed ID: 10724011
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antineoplastic effective antibiotics from Streptomycetes].
    Strauss D
    Arzneimittelforschung; 1967 Jun; 17(6):693-706. PubMed ID: 4878755
    [No Abstract]   [Full Text] [Related]  

  • 38. Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form.
    Kidani Y; Inagaki K; Iigo M; Hoshi A; Kuretani K
    J Med Chem; 1978 Dec; 21(12):1315-8. PubMed ID: 722741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and antitumor activities of beta-(1-->6) branched (1-->3)-beta-D-glucan derivatives.
    Usui S; Tomono Y; Sakai M; Kiho T; Ukai S
    Biol Pharm Bull; 1995 Dec; 18(12):1630-6. PubMed ID: 8787778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic activity of some adriamycin (NSC-123127) derivatives.
    Lenaz L; Necco A; Dasdia T; Di Marco A
    Cancer Chemother Rep; 1974; 58(6):769-76. PubMed ID: 4532629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.